Page last updated: 2024-10-25

deferoxamine and Neuroectodermal Tumors

deferoxamine has been researched along with Neuroectodermal Tumors in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Neuroectodermal Tumors: Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Timeus, F1
Valle, P1
Crescenzio, N1
Ruggieri, L1
Rosso, P1
Pagliardi, GL1
Cordero di Montezemolo, L1
Gabutti, V1
Ramenghi, U1

Other Studies

1 other study available for deferoxamine and Neuroectodermal Tumors

ArticleYear
Effect of desferrioxamine and hydroxypyridones on hemopoietic progenitors and neuroectodermal tumor cells.
    American journal of hematology, 1994, Volume: 47, Issue:3

    Topics: Antithyroid Agents; Deferoxamine; Dose-Response Relationship, Drug; Hematopoiesis; Hematopoietic Ste

1994